Insider buying
~$670K55K sh @ $12.19
Traded Aug 15, 2025 · filed 5 days later
A major shareholder of Atara Biotherapeutics paid $670K out of pocket for Atara Biotherapeutics shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Aug 18, 2025 · Filed Aug 20, 2025
Atara Biotherapeutics's Chief Accounting Officer sold $19K of Atara Biotherapeutics shares. The filing references tax withholding.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$19,372
Shares × reported transaction price
7 days after results of Aug 11, 2025, 86 days before results of Nov 12, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +7.6% | +2.1% | +5.5% |
| 30 days | +7.0% | +4.9% | +2.1% |
| 90 days | +19.6% | +4.3% | +15.3% |
| 180 days | −60.9% | +7.4% | −68.4% |
| 365 days | −15.6% | +20.5% | −36.1% |
Past results only. Not a forecast.
Insider buying
Traded Aug 15, 2025 · filed 5 days later
A major shareholder of Atara Biotherapeutics paid $670K out of pocket for Atara Biotherapeutics shares.
Yanina Grant-huerta (Chief Accounting Officer) sold ~$639 of Atara Biotherapeutics
Automatic saleYanina Grant-huerta (Chief Accounting Officer) sold ~$999 of Atara Biotherapeutics
Automatic saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.